3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
4
Phase NA
1
Phase 3
1
Phase 2/3
1
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Pain
5
Neoplasms
2
Multiple Myeloma
2
Cancer Pain
2
Squamous Cell Carcinoma of Head and Neck
1
Pain, Postoperative
1
Paget Disease, Extramammary
1
Ovarian Neoplasms
1
Lymphoma
1
Head and Neck Neoplasms
1
Fallopian Tube Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Diseases
1
Agnosia
1
Interventions
Ketamine
3
Sodium Chloride
2
Ropivacaine
2
Propofol
2
Analgesics, Opioid
2
Analgesia, Patient-Controlled
2
parecoxib
1
Tea
1
Tapentadol
1
Surveys and Questionnaires
1
Sevoflurane
1
Saline Solution
1
Lidocaine
1
Ketorolac
1
Ibuprofen
1
Epinephrine
1
Dexamethasone
1
Codeine
1
Clonidine
1
Circumcision, Male
1
Celecoxib
1
Anesthesia, General
1
Acupuncture Therapy
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Agnosia
×
Acetaminophen
×
Clear all
NCT00299039
2009-02-02
T3AI
Nova Scotia Health Authority
Phase 3
Completed
150 enrolled